Literature DB >> 25364396

Deciding site of biopsy at metastatic relapse: reply.

Filip Janku1.   

Abstract

Year:  2014        PMID： 25364396      PMCID： PMC4206654          DOI： 10.1177/1758834014551937

Source DB:  PubMed          Journal:  Ther Adv Med Oncol        ISSN： 1758-8340            Impact factor:   8.168


× No keyword cloud information.
  4 in total

1.  Deciding site of biopsy at metastatic relapse.

Authors:  Ajit Venniyoor
Journal:  Ther Adv Med Oncol       Date:  2014-11       Impact factor: 8.168

2.  PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer.

Authors:  Jeanette Dupont Jensen; Anne-Vibeke Laenkholm; Ann Knoop; Marianne Ewertz; Raj Bandaru; Weihua Liu; Wolfgang Hackl; J Carl Barrett; Humphrey Gardner
Journal:  Clin Cancer Res       Date:  2010-10-12       Impact factor: 12.531

Review 3.  Tumor heterogeneity in the clinic: is it a real problem?

Authors:  Filip Janku
Journal:  Ther Adv Med Oncol       Date:  2014-03       Impact factor: 8.168

4.  Use of research biopsies in clinical trials: are risks and benefits adequately discussed?

Authors:  Michael J Overman; Janhavi Modak; Scott Kopetz; Ravi Murthy; James C Yao; Marshall E Hicks; James L Abbruzzese; Alda L Tam
Journal:  J Clin Oncol       Date:  2012-11-05       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.